Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 116441 - 116460 out of 488784 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Croatia | (L01FF02) pembrolizumab | Keytruda | konc. za otop. za inf., boč. stakl. 1x100 mg/4 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Endometrial Neoplasms | MerckSharp&DohmeB.V. / Schering-PloughLaboNV |
| Croatia | (L01FF03) durvalumab | Imfinzi | konc. za otop. za inf., boč. stakl. 1x120 mg/2,4 ml (50mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB / AstraZenecaPharmaceuticalsLP |
| Croatia | (L01FF03) durvalumab | Imfinzi | konc. za otop. za inf., boč. stakl. 1x500 mg/10 ml (50mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB / AstraZenecaPharmaceuticalsLP |
| Croatia | (L01FF05) atezolizumab | Tecentriq | konc. otop. za inf., boč. 1x1200 mg/20 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheRegistrationGmbH / RochePharmaAG |
| Croatia | (L01FF05) atezolizumab | Tecentriq | konc. otop. za inf., boč. 1x840 mg/14 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheRegistrationGmbH / RochePharmaAG |
| Croatia | (L01FF06) cemiplimab | Libtayo | konc. za otop. za inf., boč. 1x350 mg/7 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | RegeneronIrelandDesignedActivityCompany(DAC) / RegeneronIrelandDAC |
| Croatia | (L01FG01) bevacizumab | Abevmy | konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | MylanIREHealthcareLtd / McDermottLaboratoriesLimitedt/aMylanDublinBiologics,MylanGermanyGmbH |
| Croatia | (L01FG01) bevacizumab | Abevmy | konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | MylanIREHealthcareLtd / McDermottLaboratoriesLimitedt/aMylanDublinBiologics,MylanGermanyGmbH |
| Croatia | (L01FG01) bevacizumab | Alymsys | konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | MabxienceResearchS.L. / GHGenhelixS.A. |
| Croatia | (L01FG01) bevacizumab | Alymsys | konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | MabxienceResearchS.L. / GHGenhelixS.A. |
| Croatia | (L01FG01) bevacizumab | Avastin | konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | RocheRegistrationGmbH / Roche |
| Croatia | (L01FG01) bevacizumab | Avastin | konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | RocheRegistrationGmbH / Roche |
| Croatia | (L01FG01) bevacizumab | Mvasi | konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Peritoneal Neoplasms; Ovarian Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms | AmgenTechnology(Ireland)UC / AmgenTechnology(Ireland)UC |
| Croatia | (L01FG01) bevacizumab | Mvasi | konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Peritoneal Neoplasms; Ovarian Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms | AmgenTechnology(Ireland)UC / AmgenTechnology(Ireland)UC |
| Croatia | (L01FG01) bevacizumab | Oyavas | konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | STADAArzneimittelAG / GHGENHELIXS.A. |
| Croatia | (L01FG01) bevacizumab | Oyavas | konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | STADAArzneimittelAG / GHGENHELIXS.A. |
| Croatia | (L01FG02) ramucirumab | Cyramza | konc. za otop. za inf., boč. stakl. 2x10 ml (10 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms | EliLillyNederlandB.V. / Lilly,S.A. |
| Croatia | (L01FX02) gemtuzumab ozogamicin | Mylotarg | praš. za konc. za otop. za inf., boč. stakl. 1x5 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerEuropeMAEEIG / PfizerIrelandPharmaceuticals |
| Croatia | (L01FX04) ipilimumab | Yervoy | konc. za otop. za inf., boč. stakl. 1x10 ml (5 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Mesothelioma, Malignant; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG / CATALENTANAGNIS.R.L.,SwordsLaboratoriesT/ABristol-MyersSquibbCruiserathBiologics |
| Croatia | (L01FX06) dinutuximab beta | Qarziba | konc. za otop. za inf., boč. stakl. 1x20 mg (4,5 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Neuroblastoma | EUSAPharma(Netherlands)B.V. / MillmountHealthcareLtd |
Pages
